PANEL DISCUSSION: Where Are We Now & Where Are We Going?

Time: 9:30 am


This panel will set out to address

  • Where have the current cytokine engineering strategies taken us and what can we learn from this?
  • Assessing the latest clinical work with lesser known and novel cytokines
  • Assessing the fields biggest roadblocks for moving current promising pre-clinical candidates into the clinic
  • Assessing the role of combination therapies with cytokine targeted therapies? – Where is there proven synergy?